Adusumilli, P. S., Cherkassky, L., Villena-Vargas, J., Colovos, C., Servais, E., Plotkin, J., . . . Sadelain, M. (2014). Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity. Sci Transl Med.

Adusumilli, Prasad S., Leonid Cherkassky, Jonathan Villena-Vargas, Christos Colovos, Elliot Servais, Jason Plotkin, David R. Jones, and Michel Sadelain. "Regional Delivery of Mesothelin-targeted CAR T Cell Therapy Generates Potent and Long-lasting CD4-dependent Tumor Immunity." Sci Transl Med 2014.

Adusumilli, Prasad S., et al. "Regional Delivery of Mesothelin-targeted CAR T Cell Therapy Generates Potent and Long-lasting CD4-dependent Tumor Immunity." Sci Transl Med 2014.